MétaCan
Menu
Back to cohort
Record W3210306469 · doi:10.15252/emmm.202115098

P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease

2021· article· en· W3210306469 on OpenAlexaff
Juan Lantero‐Rodriguez, Anniina Snellman, Andréa L. Benedet, Marta Milà‐Alomà, Elena Camporesi, Laia Montoliu‐Gaya, Agathe Vrillon, Thomas K. Karikari, Juan Domingo Gispert, Gemma Salvadó, Mahnaz Shekari, Christina E. Toomey, Tammaryn Lashley, Henrik Zetterberg, Marc Suárez‐Calvet, Gunnar Brinkmalm, Pedro Rosa‐Neto, Kaj Blennow

Bibliographic record

VenueEMBO Molecular Medicine · 2021
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsMontreal Neurological Institute and HospitalMcGill University
FundersH2020 European Research CouncilOlav Thon StiftelsenDemensfondenReta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology,University College LondonNational Institutes of HealthOrionin TutkimussäätiöUK Dementia Research InstituteVetenskapsrådetAcademy of FinlandFondation Vaincre AlzheimerMinisterio de Ciencia, Innovación y UniversidadesEU Joint Programme – Neurodegenerative Disease ResearchGun och Bertil Stohnes StiftelseEuropean CommissionInstituto de Salud Carlos IIIFamiljen Erling-Perssons StiftelseAlzheimer's Drug Discovery FoundationNational Institute on AgingAlzheimer's Association
KeywordsBiomarkerDiseaseMedicineComputational biologyOncologyInternal medicineBiologyGenetics

Abstract

fetched live from OpenAlex

Alzheimer's disease (AD) is characterised by a long preclinical phase. Although phosphorylated tau (p-tau) species such as p-tau217 and p-tau231 provide accurate detection of early pathological changes, other biomarkers capable of staging disease progression during preclinical AD are still needed. Combining exploratory and targeted mass spectrometry methods in neuropathologically confirmed brain tissue, we observed that p-tau235 is a prominent feature of AD pathology. In addition, p-tau235 seemed to be preceded by p-tau231, in what appeared to be a sequential phosphorylation event. To exploit its biomarker potential in cerebrospinal fluid (CSF), we developed and validated a new p-tau235 Simoa assay. Using three clinical cohorts, we demonstrated that (i) CSF p-235 increases early in AD continuum, and (ii) changes in CSF p-tau235 and p-tau231 levels during preclinical AD are consistent with the sequential phosphorylation evidence in AD brain. In conclusion, CSF p-tau235 appears to be not only a highly specific biomarker of AD but also a promising staging biomarker for the preclinical phase. Thus, it could prove useful tracking disease progression and help enriching clinical trial recruitment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.535
Threshold uncertainty score0.995

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.100
GPT teacher head0.411
Teacher spread0.311 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations57
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueEMBO Molecular MedicineSame topicAlzheimer's disease research and treatmentsFrench-language works237,207